Regulus Therapeutics
RGLS
#7340
Rank
โ‚ฌ0.50 B
Marketcap
7,28ย โ‚ฌ
Share price
0.00%
Change (1 day)
455.85%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: โ‚ฌ0.50 Billion

On August 27, 2025 Regulus Therapeutics had a market cap of โ‚ฌ0.50 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ0.48 B396.14%
2024โ‚ฌ96.93 M313.97%
2023โ‚ฌ23.41 M8.87%
2022โ‚ฌ21.5 M-47.03%
2021โ‚ฌ40.6 M-41.75%
2020โ‚ฌ69.7 M317.4%
2019โ‚ฌ16.69 M132.8%
2018โ‚ฌ7.17 M-92.04%
2017โ‚ฌ90.1 M-20.41%
2016โ‚ฌ0.11 B-73.05%
2015โ‚ฌ0.42 B-34.93%
2014โ‚ฌ0.64 B188.67%
2013โ‚ฌ0.22 B31.03%
2012โ‚ฌ0.17 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
โ‚ฌ85.68 B 16,894.99%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚ฌ29.76 B 5,803.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ107.77 B 21,276.27%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ220.33 B 43,603.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ83.13 B 16,390.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
โ‚ฌ27.35 M-94.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚ฌ2.65 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ27.78 B 5,411.05%๐Ÿ‡บ๐Ÿ‡ธ USA